Latest / Buffalo News Today | 2 Min News | The Daily News Now!
Personalized Cancer Vaccine Shows Promise | Buffalo News
Merck and Moderna are revolutionizing cancer treatment with a personalized mRNA vaccine that, when paired with Keytruda, slashes melanoma recurrence and death risk by 44%—offering new hope for stage three and four patients. This breakthrough, tailored to each patient’s tumor, is being tested across other cancers with specific mutations, signaling a major shift toward precision medicine. While long-term data is still pending, early results promise to reshape how we fight cancer—one patient at a time. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.